Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors.
Teixeira L, Medioni J, Garibal J, Adotevi O, Doucet L, Durey MD, Ghrieb Z, Kiladjian JJ, Brizard M, Laheurte C, Wehbe M, Pliquet E, Escande M, Defrance R, Culine S, Oudard S, Wain-Hobson S, Doppler V, Huet T, Langlade-Demoyen P. Teixeira L, et al. Among authors: escande m. Clin Cancer Res. 2020 Feb 1;26(3):588-597. doi: 10.1158/1078-0432.CCR-19-1614. Epub 2019 Sep 26. Clin Cancer Res. 2020. PMID: 31558479
Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.
Thalmensi J, Pliquet E, Liard C, Escande M, Bestetti T, Julithe M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, Loustau M, Caumartin J, Lachgar A, Huet T, Wain-Hobson S, Langlade-Demoyen P. Thalmensi J, et al. Among authors: escande m. Oncoimmunology. 2015 Nov 5;5(3):e1083670. doi: 10.1080/2162402X.2015.1083670. eCollection 2016 Mar. Oncoimmunology. 2015. PMID: 27141336 Free PMC article.
Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice.
Pliquet E, Ruffie C, Escande M, Thalmensi J, Najburg V, Combredet C, Bestetti T, Julithe M, Liard C, Huet T, Wain-Hobson S, Tangy F, Langlade-Demoyen P. Pliquet E, et al. Among authors: escande m. Cancer Immunol Immunother. 2019 Apr;68(4):533-544. doi: 10.1007/s00262-018-2272-3. Epub 2019 Jan 17. Cancer Immunol Immunother. 2019. PMID: 30656384 Free PMC article.
A DNA telomerase vaccine for canine cancer immunotherapy.
Thalmensi J, Pliquet E, Liard C, Chamel G, Kreuz C, Bestetti T, Escande M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, Julithe M, Bourre L, Keravel O, Clayette P, Huet T, Wain-Hobson S, Langlade-Demoyen P. Thalmensi J, et al. Among authors: escande m. Oncotarget. 2019 May 21;10(36):3361-3372. doi: 10.18632/oncotarget.26927. eCollection 2019 May 21. Oncotarget. 2019. PMID: 31164958 Free PMC article.
APOBEC3A intratumoral DNA electroporation in mice.
Kostrzak A, Caval V, Escande M, Pliquet E, Thalmensi J, Bestetti T, Julithe M, Fiette L, Huet T, Wain-Hobson S, Langlade-Demoyen P. Kostrzak A, et al. Among authors: escande m. Gene Ther. 2017 Feb;24(2):74-83. doi: 10.1038/gt.2016.77. Epub 2016 Nov 18. Gene Ther. 2017. PMID: 27858943
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.
Anna F, Bole-Richard E, LeMaoult J, Escande M, Lecomte M, Certoux JM, Souque P, Garnache F, Adotevi O, Langlade-Demoyen P, Loustau M, Caumartin J. Anna F, et al. Among authors: escande m. J Immunother Cancer. 2021 Mar;9(3):e001998. doi: 10.1136/jitc-2020-001998. J Immunother Cancer. 2021. PMID: 33737343 Free PMC article.
Notchless is required for axial skeleton formation in mice.
Beck-Cormier S, Escande M, Souilhol C, Vandormael-Pournin S, Sourice S, Pilet P, Babinet C, Cohen-Tannoudji M. Beck-Cormier S, et al. Among authors: escande m. PLoS One. 2014 May 29;9(5):e98507. doi: 10.1371/journal.pone.0098507. eCollection 2014. PLoS One. 2014. PMID: 24875805 Free PMC article.
173 results